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The prevalence of panic disorder in patients with chronic obstructive pulmonary disease (COPD)
is up to 10 times greater than the overall population prevalence of 1.5e3.5%, and panic attacks
are commonly experienced. When present, clinically significant anxiety decreases quality of life
for COPD patients, and also increases health care costs. Therefore, understanding why COPD
patients have such high rates of panic attacks and panic disorder is important for optimal
management of COPD. The cognitive model of panic anxiety is the most widely accepted theory
of panic attacks and panic disorder in physically healthy adults. According to this model, panic
attacks occur when catastrophic misinterpretations of ambiguous physical sensations (such as
shortness of breath or increased heart rate) increase arousal, creating a positive feedback loop
that results in panic. As the major symptom of a terminal illness that threatens our most basic
physical requirement, dyspnea in COPD is open to catastrophic misinterpretation. There is some
experimental and clinical evidence for the applicability of the cognitivemodel of panic anxiety in
COPD, and of the utility of cognitive behavior therapy (CBT), based on this model, for treating
anxiety symptoms and panic attacks in COPD patients. However, there is much need for further
studies. Evidence is increasing that mental health professionals, in collaboration with multi-
disciplinary pulmonary teams, potentially have key roles to play in preventing and treating panic
attacks and panic disorder in COPD patients. This review addresses diagnosis, epidemiology,
theoretical conceptualizations, treatment, and recommendations for future research.
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Chronic obstructive pulmonary disease (COPD) is a major
global cause of disability and death, with anxiety symptoms
among the most frequently reported predictors of impaired
quality of life and functional status.1e10 Of the nine anxiety
disorders listed in the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV), the incidence of
one, panic disorder, is remarkably high in COPD.11e13 When
panic attacks and panic disorder (panic-spectrum psycho-
pathology) are comorbid with COPD, they are associated
with increased symptom reporting, worse quality of life,
more use of medical treatments, and increased rates of
hospitalisation.14e17 The aim of this paper is to, from
a cognitive behavioral perspective, review developments in
experimental and clinical research on panic-spectrum
psychopathology in COPD. The review will address diag-
nosis, epidemiology, theoretical conceptualizations, treat-
ment, and recommendations for future research.
Diagnosis and epidemiology of panic-spectrum
psychopathology in COPD
Using criteria from the DSM-IV (American Psychiatric Asso-
ciation, 1994, p. 432), a panic attack is “A discrete period
of intense fear or discomfort”, accompanied by at least
four of a possible 13 symptoms of physical arousal
(including sensations of shortness of breath or smothering)
and fear (of imminent loss of control, madness or death).11
When recurrent panic attacks are experienced by a patient
with COPD, but the attacks occur only in association with
severe breathing difficulties during infective exacerbations
of the illness, then the appropriate diagnosis is not panic
disorder but anxiety disorder due to a general medical
condition.18 Panic disorder can be diagnosed (using DSMeIV
criteria) in the context of COPD only when an individual
experiences recurrent, uncued panic attacks; that is, he or
she must experience at least some attacks that are not
triggered by an identifiable internal stressor such as an
infective exacerbation of the illness, or an external stressor
such as physical exertion. Regular attacks for which trig-
gers, such as physical exertion, can be identified may also
be experienced, but would not in themselves be sufficient
to meet criteria for the diagnosis of panic disorder.18,19 For
this diagnosis, a series of unexpected panic attacks must
further be followed by at least a month of persistentconcern about having further attacks, worry about the
implications or consequences of such attacks, and/or
significant behavioral change related to the attacks such as
the development of agoraphobic avoidance.11 Avoidance of
situations in which it is feared attacks may occur develops
in approximately one third of COPD patients with panic
disorder.18 In summary, panic disorder is distinguishable in
COPD patients by anticipatory anxiety about future panic
attacks, and the unexpected and unpredictable nature of at
least some of these attacks, that do not occur solely in
response to situations inevitably causing shortness of
breath in COPD (such as physical exertion, or infective
exacerbations).
There is evidence that panic attacks are a frequent
experience for patients with COPD. In a large community
sample, postmenopausal women with a history of COPD
were significantly more likely to report having had panic
attacks (odds ratio 4.13; confidence interval 2.65e6.43)
than were women without COPD.20 Another study of
a convenience sample of 48 outpatients with COPD found
that 37% had experienced a panic attack in the previous
three weeks.21 In a more recent study, also using a conve-
nience sample, 63% (nZ 37) of subjects had experienced at
least one panic attack in the previous year, and 51%
(nZ 19) of these an attack in the previous month.22
Estimates of the prevalence of panic disorder in COPD
have ranged from 6% to 67%.8,23 The wide range may reflect
methodological differences between studies in regard to
sample selection and size, measurement methods, and
thresholds for syndrome identification.8,14,23e26 Neverthe-
less, the prevalence is clearly considerably higher than that
of 1.5e3.5% for the population in general, perhaps as much
as 10 times so.11,12 This higher prevalence of panic disorder
in COPD also contrasts with the repeated finding in
community-based studies that rates of panic disorder in
older adults are lower than those in younger and middle-
aged adults, and in the range of 0.04e1.0%.19,27 The
authors of some epidemiological studies have commented
on the high comorbidity between panic disorder and
chronic physical illness in the elderly.27e29 Such comorbid-
ity has been noted to contribute to the chronicity of panic
disorder, and to complicate its treatment.16,30,31
The majority of studies thus far investigating the
impacts of anxiety on COPD patients have only measured
anxiety symptoms by self-report questionnaire. Question-
naire based data does not allow diagnosis of panic disorder,
or indeed any psychiatric disorder. However, high scores on
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clinically significant anxiety symptoms, and a subset of
COPD patients with such scores would meet DSM-IV criteria
for panic disorder if a formal diagnostic interview was
administered. When present, symptoms of anxiety have
been found to influence self-management of COPD, and
even influence mortality.32e35 Anxiety symptoms and panic
attacks have been found to predict increased duration and
frequency of hospital admissions for acute exacerbations of
COPD, and high utilization of medical services, at signifi-
cantly increased financial cost.15e17,36e41 Yellowlees and
colleagues found that COPD patients with comorbid panic
disorder had more frequent hospital admissions than other
COPD patients, and the admissions were twice as lengthy.14
The cognitive model of panic-spectrum
psychopathology and its applicability in COPD
Panic attacks and panic disorder have, for the past three
decades, been the subject of considerable theoretical
controversy. Biological theories have primarily linked panic
with disorders of respiration: in particular, hyper-
ventilation.42e45 These theories have been criticized on the
grounds that hyperventilation has not been found to be
particular to patients with panic disorder, and that carbon
dioxide concentrations used in supporting experiments
have been higher than those that could arise naturally.46e48
Psychological theorists have argued that biological models
are neither necessary nor sufficient to explain the occur-
rence of panic attacks, and the development of panic
disorder.47,49,50 The most widely accepted theory of panic-
spectrum psychopathology, which has risen to prominence
in the last 20 years, is Clark’s cognitive model (see
Fig. 1).51,52 This model is based on Beck’s (1976) formula-
tion of an individual’s beliefs as providing the causal basis
for misappraisals, which then lead to the development of
emotional disorders.53 In the model, catastrophic misin-
terpretations of ambiguous bodily sensations (such as
shortness of breath, rapid heart rate and light-headedness)
increase arousal, creating a positive feedback loop that
results in a panic attack. Such sensations may be inter-
preted as meaning that the individual may die (for
example, by suffocation, heart attack, or “stroke”
respectively), become insane, or otherwise lose control. ATrigger stimulus
(Internal or external)
Perceived threat
Interpretation of
sensations as Apprehension
catastrophic
Body sensations
Figure 1 Clark’s model of the suggested sequence of events
in a panic attack. From Clark (1986, p. 463).substantial number of studies with physically healthy
younger adults have provided support for the cognitive
model.54e60 The model has also provided the rationale for
cognitive behavior therapy (CBT) for panic-spectrum
psychopathology, a treatment of proven efficacy in the
physically healthy.61e63 CBT is an action-oriented treat-
ment in which both cognitive (e.g. identification and chal-
lenging of interpretation errors) and behavioral (e.g.
planned exposure to avoided sensations and situations)
strategies are used to interrupt the panic cycle and facili-
tate more adaptive responses.61e63 There is increasing
evidence that CBT for panic-spectrum psychopathology is
effective because it is able to successfully decrease cata-
strophic beliefs about ambiguous physical sensations, as
predicted by the cognitive model.60,64
A crucial difference between physically healthy people
and those with COPD is that in the latter, breathing, the
most basic of all physical functions necessary for life, is
objectively threatened (as measured by tests of lung
function) and subjectively difficult. Dyspnea can be an
unpleasant and potentially frightening experience at any
time, and, as the key symptom of an eventually fatal illness
like COPD, it is an ambiguous sensation open to cata-
strophic interpretation. Clinical and experimental studies
have found that people with panic disorder are more likely
to direct their attention toward ambiguous physical
sensations, and to interpret such sensations as threat-
ening.57,58,64e67 The threat presented by dyspnea in COPD is
consistent with the high prevalence of comorbid panic
disorder in this patient group.
The cognitive model of panic in COPD is supported by the
findings that pulmonary function and response to bron-
chodilators do not differ between COPD patients who
experience panic attacks and those who do not.21e23,25,26,68
Physiological research has demonstrated both that respi-
ratory rate is increased by anxiety, and that the resulting
rapid, shallow breathing pattern markedly worsens dyspnea
in COPD.69,70 In healthy individuals, hyperventilation lowers
the level of carbon dioxide in the blood, leading to typical
panic symptoms such as light-headedness, numbness,
tingling sensations, and shortness of breath.70 For patients
with lung disease, in addition hyperventilation can directly
produce bronchoconstriction, probably by exposing the
airways to cool, dry air.71 Increased frequency of breathing
also predisposes to dynamic hyperinflation, due to the slow
time constant for lung deflation. Hyperinflation increases
the elastic load and work and effort of breathing, reduces
inspiratory reserve capacities, and exacerbates dyspnea.72
The cognitive model predicts that only those individuals
with COPD who interpret their physical symptoms cata-
strophically should experience panic attacks.
Porzelius and colleagues (1992) and Moore and Zebb
(1999) investigated the presence of catastrophic cognitions
in COPD patients.21,25 The first group reported that the 37%
of their subjects who had experienced panic attacks had
significantly more catastrophic thoughts about somatic
symptoms (as measured by questionnaire) than subjects
who had not experienced panic attacks.21 Thirty two
percent of subjects in Moore and Zebb’s study reported
symptoms compatible with a diagnosis of panic disorder,
and these subjects also had significantly higher rates of
catastrophic cognitions than subjects without panic-
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studies provide some support for the cognitive model of
panic disorder in patients with COPD. However, neither
study included formal diagnoses of panic attacks and panic
disorder, thereby limiting the applicability of the findings.
In Vogele and von Leupoldt’s (2008) study of 20 hospitalized
patients with COPD, 11 (55%) were diagnosed with an
anxiety disorder, eight of these with panic disorder.26 Those
COPD patients with an anxiety disorder reported signifi-
cantly higher levels of physical symptom perception,
despite their lung function being no worse than that of
patients without an anxiety disorder.26 This study indicates
that heightened symptom perception and misinterpreta-
tions of physical sensations are associated with panic
disorder in COPD, with the qualification that patients were
tested during an exacerbation.
Recently, 20 clinically well COPD patients with panic-
spectrum psychopathology were compared on a test of
dyspnea perception with 20 age-matched COPD patients
without psychopathology and 20 healthy, age-matched
matched control subjects.68 The COPD panic group rated
themselves as more short of breath during inspiratory
resistive loading than did the COPD group without panic,
despite there being no differences between the two in
respiratory function.68 This heightened dyspnea perception
in the COPD panic group provides evidence of the somato-
sensory amplification that would be predicted by the
cognitive model of panic anxiety.
In summary, dyspnea in COPD lends itself to interpre-
tation as an extreme and frightening symptom. Anxiety
increases respiratory rate, and the hyperventilation that
results will significantly exacerbate dyspnea in the dis-
ease.69e72 Catastrophic interpretation may then follow, as
in the vicious cycle of panic, and agoraphobic avoidance
behavior may also ensue.73Cognitive behavior therapy for panic-spectrum
psychopathology in COPD
Simon and Fischmann brought to attention the concept that
“COPD with comorbid panic disorder provides an example
of a case in which the medical disorder is chronic, yet
intervention for panic disorder may provide symptomatic
relief for both disorders” (2005, p. 9).16 As stated above,
CBT is a treatment of proven efficacy for panic disorder,
and other anxiety disorders, in the physically healthy.61e63
CBT interventions for anxiety symptoms in COPD patients
not selected on the basis of existing psychopathology have
been evaluated in four randomized controlled trials.
41,74e76 One further randomized controlled trial of CBT has
included COPD patients with clinically significant anxiety
and/or depressive symptoms.77
Emery and colleagues (1998) assigned 79 subjects with
COPD to 10 weekly, group-administered sessions of
combined physical exercise, education and stress
management, education and stress management only, or
waiting list control.74 Mean anxiety scores for all three
groups at baseline were below the clinically significant
range. The stress management component was conducted
by a clinical psychologist, and consisted of weekly sessions
teaching progressive muscular relaxation, increasedawareness of thinking distortions about physical limitations
in COPD, and the emotional effects of such distortions. At
post-intervention, anxiety scores were significantly
reduced only for the combined exercise, education and
stress management condition, suggesting that physical
exercise may itself be an important component of treat-
ment.74 Unfortunately, there was no physical exercise-only
control condition, so it is unclear whether subjects’
improvement can be solely attributed to the intensive
exercise component of the program, or to exercise
combined with other strategies. There were no post-
intervention follow-up assessments.
In the trial conducted by Kunik and colleagues (2001),
one session of CBT (conducted by a geropsychiatrist) was
compared to a session of education about COPD.75 Fifty-six
(primarily male) unselected patients agreed to participate,
and 48 took part in all assessments. Components of the
group intervention included psycho-education about
anxiety, and training in breathing, relaxation, and inter-
ruption of anxiety-provoking thoughts. Psycho-education
was also provided about exposure therapy, a key CBT
technique which involves patients systematically exposing
themselves to safe, but avoided, anxiety-provoking situa-
tions (e.g. stair climbing) and symptoms until the intensity
of their anxiety reaction decreases.64 Intervention subjects
were given a workbook, and contacted weekly by phone for
six weeks to monitor their compliance in practicing skills.
Mean scores for both groups before intervention on
measures of anxiety and depression were in the low clinical
range. Scores of intervention, but not control, subjects
decreased significantly post-intervention to below the
clinical range.75 Kunik and colleagues’ study is weakened by
a follow-up period of only six weeks, and pulmonary reha-
bilitation attendance was not controlled for, but the study
provides some of the first evidence that as little as two
hours of group-administered CBT may have some impact on
COPD patients’ anxiety symptoms.
In de Godoy and de Godoy’s (2003) study, 30 unselected
patients (22 male) attending a pulmonary rehabilitation
program were randomized into either 12 sessions of group
psychotherapy, primarily comprising cognitive therapy, or
routine care.76 Both groups had mean scores in the lower
end of the clinical range on measures of anxiety and
depression at study entry. Post-intervention, while both
groups had improved significantly on the six minute walking
test,78 only the CBT group had a significant decrease in
anxious and depressive symptoms to below the clinical
range. Unlike Emery and colleagues (1998), de Godoy and
de Godoy (2003) controlled for attendance of pulmonary
rehabilitation, so the decreases in anxiety and depression
scores cannot be attributed to physical exercise.76
However, the study would have been improved by the
inclusion of follow-up assessments.
In the fourth study of unselected patients, the efficacy
of a four session CBT intervention in preventing the
development and/or worsening of panic-spectrum psycho-
pathology and anxiety symptoms in COPD patients, over an
18 month follow-up period, was evaluated.41 The study’s
aim was to intervene early with individuals at risk of panic
disorder, to prevent any personal and economic impacts of
the disorder becoming established.15e17,30,31 Forty-one
COPD patients (18 male) without panic disorder, who had
1250 N. Livermore et al.undergone pulmonary rehabilitation, were randomized to
either a CBT self-management intervention or routine care
condition. Components of the standardized, individually
administered intervention, conducted by a clinical
psychologist, included psycho-education, cognitive
therapy, training in “pursed lip” breathing and activity
planning and “pacing”, and problem solving about barriers
to physical exercise and good coping. There were no
differences between the groups on outcome measures at
baseline, with 19% (nZ 4) of CBT and 30% (nZ 6) of routine
care participants having experienced at least one panic
attack in the previous month. Mean scores for both groups
on measures of anxiety and depression were below the
clinical range. By 18 month follow-up assessment, 60%
(nZ 12) of routine care subjects had experienced at least
one panic attack in the previous six months, and 17%
(nZ 2) of these were diagnosed with panic disorder. No
subjects in the CBT group had any panic attacks during the
follow-up period. Anxiety symptoms and catastrophic
cognitions about breathing also increased in the routine
care group and decreased in the CBT group, and there was
a significant reduction in the number of COPD-related
hospital admissions in the latter group between six and
twelve month follow-ups. The absolute risk reduction
provided by the intervention was 43%, with three patients
being treated to prevent one case of panic attacks devel-
oping during the 18 month follow-up phase.41 While the
relatively small sample is a limitation of the study, it
provides the first evidence that a brief CBT self-manage-
ment intervention, added to pulmonary rehabilitation, may
help to prevent the high personal and social costs of
comorbid panic-spectrum psychopathology in COPD.
In the only randomized controlled trial yet conducted
that has included some patients with diagnosed psycho-
logical disorders, Kunik and co-workers’ (2007) conducted
a large trial comparing 8 sessions of multi-component group
CBT to 8 sessions of group COPD education. The sample
comprised 238 (primarily male) COPD patients with at least
moderate anxiety and/or depressive symptoms.77 The CBT
intervention included psycho-education, relaxation
training, cognitive therapy, problem solving, and sleep
management skills. Patients in both CBT and COPD educa-
tion conditions showed similar, albeit limited, improve-
ments (from the “moderate” to the “mild” category) on
measures of anxiety and depressive symptoms that were
maintained over a 10 month follow-up period. While at
baseline assessment 38% of subjects were diagnosed with
unspecified anxiety disorders, diagnostic information post-
intervention was not reported.77 There are a number of
possible reasons for the lack of superiority of CBT over
COPD education in this study. First, the education condition
is likely to have had some inadvertent anxiety-reducing
effect, as it included breathing management strategies,
along with discussion of physical exercise.77 Also, the CBT
intervention, which was designed to treat both anxiety and
depressive symptoms, may have been too general in
content to fully benefit patients with moderate levels of
psychopathology.79 The group-administered format may
have also had insufficient flexibility to address the needs of
a heterogeneous sample of COPD patients with mixed
psychopathologies.80 Once anxiety disorders have devel-
oped comorbidly with respiratory diseases (as in nearly 40%of Kunik and colleagues’ subjects) treatment may be more
difficult and an eight session group intervention insufficient
for complete symptom resolution.16,30,79
In summary, three of the four studies of unselected
patients outlined above have supplied evidence that groupor
individually administered CBTcan effectively reduce anxiety
symptoms in COPD patients who do not yet meet DSM-IV
criteria for the diagnosis of panic disorder, and may also
prevent panic-spectrum psychopathology developing.41,75,76
However, from the study conducted by Kunik and colleagues
(2007), there is little evidence to date that CBT, when group
administered and not specifically targeted toward particular
disorders, is effective for diagnosed panic disorder or other
psychiatric disorders in COPD patients.77 There is clearly
considerable need for the first randomized controlled trials
of CBT specific for panic disorder in COPD, with the CBT
initially being individually administered.
Cognitive behavior therapy for panic-spectrum
psychopathology in COPD: special issues
The treatment of two COPD patients with comorbid panic
disorder has been described in detail.79 On the basis of
these case studies, and in the absence of any specifically
targeted randomized controlled trials, we make some
preliminary suggestions about CBT for panic disorder in
COPD. Planned exposure to avoided situations and physical
sensations, providing evidence that disconfirms cata-
strophic interpretations, is one of the primary components
of CBT for panic disorder in the physically healthy.60,64 Such
exposure is consequently also necessary in CBT for panic
disorder in COPD, to help modify any heightened percep-
tion and catastrophic interpretations of dyspnea associated
with activities of daily life. Twelve or more sessions of
individual treatment could therefore be required, a finding
that may in part account for the disappointing results of the
randomized controlled trial by Kunik and colleagues (2007)
discussed above.77,79 Graded exposure programs should be
developed in consultation with patients’ respiratory physi-
cians, and only commence after medical treatment has
been optimized. Realistic goals for situational exposure,
which take into account patients’ stage of illness, need to
be set. Interoceptive exposure tasks (e.g. planned hyper-
ventilation) can be undertaken, but only when patients are
not unwell with an infective exacerbation. Regular,
systematic exposure to experiencing and managing dyspnea
during physical exercise can also be achieved via pulmonary
rehabilitation programs, which are therefore likely to assist
in the treatment of panic-spectrum psychopathology in
COPD.81
Pulmonary rehabilitation has itself been associated with
at least short-term reductions in symptoms of anxiety and
depression.82 Coventry (2009) concluded that exposure to
intensive physical exercise is the pulmonary rehabilitation
component likely responsible for decreasing anxious and
depressive symptoms in patients.81,83 However, these
psychological benefits have declined in the 6e12 months
following attendance (more quickly than the physical
benefits) and are no longer evident by 12 month follow-
up.81,82,84,85 Further, there is no evidence thus far that
pulmonary rehabilitation alone can decrease symptoms of
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intervention from mental health specialists will be required
in these circumstances.Future research: where next?
Further experiments investigating aspects of the cognitive
model in COPD patients with panic-spectrum psychopa-
thology are of more than theoretical interest; they may also
have implications for patient management. Some
researchers have suggested parallels between dyspnea and
chronic pain, with distinguishable sensory (intensity) and
affective (unpleasantness) components that each contribute
to the overall perception of the two sensations.86e89
Research on these two dimensions of dyspnea is in its
preliminary stages. Most studies thus far have been con-
ducted with healthy volunteers, although there are several
with mixed samples of COPD patients 90e93
Studies of physically healthy patients with panic
attacks/disorder, showing that these patients catastrophi-
cally overinterpret both the intensity and the dangerous-
ness of ambiguous physical sensations, lead to the
predictions that the correlation between the intensity and
unpleasantness of dyspnea will be still be high in COPD
patients with panic attacks/disorder (as it is in people
generally), but that ratings of both intensity and unpleas-
antness will be higher than for COPD patients without
panic.54e60 In the resistive loading experiment recently
reported, COPD subjects with panic attacks were asked to
rate only the sensory intensity of their dyspnea (using the
Borg Scale) and rated it significantly more highly than did
COPD subjects without panic attacks. This result indicated
that COPD patients with panic share with healthy panic
patients the bias toward a more extreme perception
(somatosensory amplification) of an ambiguous physical
sensation, in this case dyspnea. In future, having COPD
patients with and without panic-spectrum psychopathology
separately rate dyspnea intensity and distress could be
useful, with both components potentially able to be
decreased by psychological treatment.94
Larger scale prevention trials for panic-spectrum
psychopathology, with brief CBT self-management inter-
ventions for unselected COPD patients perhaps being linked
to pulmonary rehabilitation programs, are warranted by the
results of the study conducted by Livermore and
colleagues.41 Whether this type of preventative interven-
tion can be successfully implemented in a group format
requires investigation, but even individual administration
could be justified by cost savings to health agencies. Adding
a preventative CBT intervention to pulmonary rehabilita-
tion programs could lay the foundation for the treatment of
panic disorder when this is required for some patients,
while at the same time decreasing the possibility of the
disorder developing in some others. The use of pre and post
questionnaires could assist in identifying individuals who
have clinically significant symptoms of psychological
distress that necessitate further intervention, in line with
the “stepped care” approach to CBT intervention with
COPD patients suggested by Coventry and Hind (2007).82
No randomized controlled trials of CBT specifically for
panic disorder in COPD have yet been conducted, so theprimary clinical research need in the area is for such trials.
The CBT should be specifically focused, as particular
strategies and techniques are required for particular
psychological disorders.95 Treatment should be adminis-
tered individually (rather than in a group format) initially,
as doing so allows sufficient flexibility to meet the thera-
peutic needs of particular patients.80 Trials of the efficacy
of a group-administered format can then follow. Interven-
tions should be specified clearly enough to allow replication
studies. Researchers should ensure that participants master
relevant techniques, such as breathing retraining, and that
health professionals who implement interventions are
themselves skilled in CBT.96 Long-term follow-up is also
required, to provide evidence as to whether any beneficial
effects of CBT are maintained e only then will such treat-
ments become viable additions to routine care.
Conclusions
Panic attacks and panic disorder are quite frequent co-
morbidities in COPD, and this high prevalence of panic-
spectrum psychopathology in COPD is predicted by the
cognitive model of panic anxiety. Randomized controlled
trials of CBT, developed from the cognitive model, for panic
disorder in COPD are yet to be conducted. However, in the
meantime evidence has accrued that CBT with COPD
patients is an effective intervention for anxiety symptoms
and comorbid panic attacks, can prevent the development
of panic disorder, and is also associated with cost savings to
health agencies. Mental health professionals, in collabora-
tion with multi-disciplinary pulmonary teams, have key
roles to play in preventing and treating the added disability
of comorbid panic-spectrum psychopathology in COPD.
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